156 related articles for article (PubMed ID: 19001119)
1. Preparation and stability of voriconazole eye drop solution.
Dupuis A; Tournier N; Le Moal G; Venisse N
Antimicrob Agents Chemother; 2009 Feb; 53(2):798-9. PubMed ID: 19001119
[TBL] [Abstract][Full Text] [Related]
2. [Stability and in vitro activity of voriconazole eyedrops at a concentration of 3 microg/mL].
Isla Tejera B; Garzas Martín de Almagro C; Cárdenas Aranzana M; Pérez Rodrigo I; Aumente Rubio MD; Gordillo Sánchez R
Farm Hosp; 2005; 29(5):331-4. PubMed ID: 16351455
[TBL] [Abstract][Full Text] [Related]
3. [Use of topical voriconazole in Alternaria keratitis].
De-Domingo-Barón B; Rodríguez-Ares T; Touriño-Peralba R; Pardo-Sánchez F; Romero-Jung P; Barcia M
Arch Soc Esp Oftalmol; 2008 Aug; 83(8):493-5. PubMed ID: 18661446
[TBL] [Abstract][Full Text] [Related]
4. Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.
Pawar P; Kashyap H; Malhotra S; Sindhu R
Biomed Res Int; 2013; 2013():341218. PubMed ID: 23762839
[TBL] [Abstract][Full Text] [Related]
5. Natamycin and voriconazole in fungal keratitis.
Das M; Murthy SI; Dikshit S; Rathi V
Arch Ophthalmol; 2011 Jun; 129(6):814; author reply 814-5. PubMed ID: 21670358
[No Abstract] [Full Text] [Related]
6. Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis.
Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
Ann Pharmacother; 2009 Dec; 43(12):2103-7. PubMed ID: 19861430
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole and fungal keratitis: a report of two treatment failures.
Giaconi JA; Marangon FB; Miller D; Alfonso EC
J Ocul Pharmacol Ther; 2006 Dec; 22(6):437-9. PubMed ID: 17238810
[TBL] [Abstract][Full Text] [Related]
8. Prospective open-label study of the administration of two-percent voriconazole eye drops.
Al-Badriyeh D; Leung L; Roydhouse T; Fullinfaw R; Daniell M; Davies GE; Stewart K; Kong DC
Antimicrob Agents Chemother; 2009 Jul; 53(7):3153-5. PubMed ID: 19433565
[TBL] [Abstract][Full Text] [Related]
9. Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections.
Sahraoui L; Chiadmi F; Schlatter J; Toledano A; Cisternino S; Fontan JE
Am J Health Syst Pharm; 2006 Aug; 63(15):1423-6. PubMed ID: 16849707
[No Abstract] [Full Text] [Related]
10. Activity of voriconazole against corneal isolates of Scedosporium apiospermum.
Shah KB; Wu TG; Wilhelmus KR; Jones DB
Cornea; 2003 Jan; 22(1):33-6. PubMed ID: 12502945
[TBL] [Abstract][Full Text] [Related]
11. Stability of extemporaneously prepared voriconazole ophthalmic solution.
Al-Badriyeh D; Li J; Stewart K; Kong DC; Leung L; Davies GE; Fullinfaw R
Am J Health Syst Pharm; 2009 Aug; 66(16):1478-83. PubMed ID: 19667005
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.
Sharma N; Chacko J; Velpandian T; Titiyal JS; Sinha R; Satpathy G; Tandon R; Vajpayee RB
Ophthalmology; 2013 Apr; 120(4):677-81. PubMed ID: 23246119
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole.
Neoh CF; Leung L; Vajpayee RB; Stewart K; Kong DC
Ann Pharmacother; 2011 May; 45(5):e24. PubMed ID: 21521864
[TBL] [Abstract][Full Text] [Related]
14. Keratomycosis in a dog treated with topical 1% voriconazole solution.
Grundon RA; O'Reilly A; Muhlnickel C; Hardman C; Stanley RG
Vet Ophthalmol; 2010 Sep; 13(5):331-5. PubMed ID: 20840112
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
Martín-Navarro CM; López-Arencibia A; Arnalich-Montiel F; Valladares B; Piñero JE; Lorenzo-Morales J
Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2111-7. PubMed ID: 23686225
[TBL] [Abstract][Full Text] [Related]
16. Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation.
El-Hadidy GN; Ibrahim HK; Mohamed MI; El-Milligi MF
Drug Dev Ind Pharm; 2012 Jan; 38(1):64-72. PubMed ID: 21696340
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Arora R; Gupta D; Goyal J; Kaur R
Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
[TBL] [Abstract][Full Text] [Related]
18. Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient.
Fianchi L; Montini L; Caira M; Voso MT; Maviglia R; Posteraro B; Pagano L
Infection; 2008 Feb; 36(1):65-7. PubMed ID: 17926005
[TBL] [Abstract][Full Text] [Related]
19. Aqueous humor concentration of voriconazole after topical administration in rabbits.
Vorwerk CK; Streit F; Binder L; Tuchen S; Knop C; Behrens-Baumann W
Graefes Arch Clin Exp Ophthalmol; 2008 Aug; 246(8):1179-83. PubMed ID: 18491124
[TBL] [Abstract][Full Text] [Related]
20. Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin.
Tu EY
Cornea; 2009 Jan; 28(1):116-9. PubMed ID: 19092423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
